Holen Sie sich die Stockscreener-App
1.79
7.01%
-0.135
Finanzdaten der Fate Therapeutics Inc-Aktie (FATE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
60.28%
2.082
|
1.299 | 1.369 | 1.741 | 1.907 |
| Operating Expenses |
3.16%
33.22
|
34.30 | 36.09 | 36.48 | 38.88 |
| Operating Income/Loss |
5.65%
-31.13
|
-33.00 | -34.72 | -34.73 | -36.97 |
| Net Income/Loss |
3.38%
-30.16
|
-31.21 | -32.37 | -32.25 | -34.07 |
| Basic Average Shares |
0.31%
120.40
|
120.03 | 0.1536 | 119.00 | 118.53 |
| Diluted Average Shares |
0.31%
120.40
|
120.03 | 0.1536 | 119.00 | 118.53 |
| Basic Earnings Per Share |
3.85%
-0.25
|
-0.26 | -0.27 | -0.27 | -0.29 |
| Diluted Earnings Per Share |
3.85%
-0.25
|
-0.26 | -0.27 | -0.27 | -0.29 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):